Literature DB >> 20639434

Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship.

Haiping Hao1, Li Lai, Chaonan Zheng, Qiong Wang, Guo Yu, Xueyan Zhou, Liang Wu, Ping Gong, Guangji Wang.   

Abstract

Although the biotransformation of ginsenosides in the gastrointestinal tract has been extensively studied, much less is known about hepatic cytochrome P450 (P450)-catalyzed metabolism. The major aims of this study were to clarify the metabolic pathway and P450 isoforms involved and to explore the structure-metabolism relationship of protopanaxatriol (PPT)-type ginsenosides in hepatic microsomes. Efficient depletion of ginsenoside Rh1, Rg2, Rf, and PPT was found, whereas the elimination of Re and Rg1, characterized by a glucose substitution at the C20 hydroxy group, was negligible in microsomal incubation systems. Based on high-performance liquid chromatography hybrid ion trap and time-of-flight mass spectrometry analysis, the oxygenation metabolism on the C20 aliphatic branch chain was identified as the predominant metabolic pathway of PPT ginsenosides in both human and rat hepatic microsomes. By a comparison with authentic standards, the C24-25 double bond was identified as one of the oxygenation sites to produce the metabolites of C20-24 epoxide (ocotillol-type ginsenosides). Both chemical inhibition and human recombinant P450 isoform assays indicated that CYP3A4 was the predominant isozyme responsible for the oxygenation metabolism of PPT ginsenosides. Enzyme kinetic evaluations in rat and human hepatic microsomes and human recombinant CYP3A4 isozyme incubation systems showed generally consistent results in that the intrinsic clearance ranked as Rf ≤ Rg2 < Rh1 < PPT, closely correlating with logP values and the number of glycosyl substitutions. Results obtained from this study suggest that CYP3A4-catalyzed oxygenation metabolism plays an important role in the hepatic disposition of ginsenosides and that glycosyl substitution, especially at the C20 hydroxy group, determines their intrinsic clearances by CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639434     DOI: 10.1124/dmd.110.033845

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Effect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule.

Authors:  Huan-Huan Pang; Meng-Yi Li; Yuan Wang; Min-Ke Tang; Chang-Hua Ma; Jian-Mei Huang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

Review 2.  Metabolism of ginseng and its interactions with drugs.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Guang-Jian Du; Zhi-Yu Zhang; Tyler Calway; Chun-Su Yuan
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

3.  Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair.

Authors:  Min Zhao; Dan-Dan Wang; Yuan Che; Meng-Qiu Wu; Qing-Ran Li; Chang Shao; Yun Wang; Li-Juan Cao; Guang-Ji Wang; Hai-Ping Hao
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

4.  Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.

Authors:  Jacob J Junco; Anna Mancha; Gunjan Malik; Sung-Jen Wei; Dae Joon Kim; Huiyun Liang; Thomas J Slaga
Journal:  Mol Cancer Res       Date:  2013-09-26       Impact factor: 5.852

5.  Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts.

Authors:  Xiaomei Fan; Yan Xu; Danni Zhu; Yibing Ji
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-23       Impact factor: 2.629

Review 6.  Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability.

Authors:  Hyeongmin Kim; Jong Hyuk Lee; Jee Eun Kim; Young Su Kim; Choong Ho Ryu; Hong Joo Lee; Hye Min Kim; Hyojin Jeon; Hyo-Joong Won; Ji-Yun Lee; Jaehwi Lee
Journal:  J Ginseng Res       Date:  2018-01-09       Impact factor: 6.060

7.  Trends in ginseng research in 2010.

Authors:  Si-Kwan Kim; Jeong Hill Park
Journal:  J Ginseng Res       Date:  2011-11       Impact factor: 6.060

8.  Identification of Human UDP-Glucuronosyltransferase 1A4 as the Major Isozyme Responsible for the Glucuronidation of 20(S)-Protopanaxadiol in Human Liver Microsomes.

Authors:  Jia Li; Chunyong He; Lianxiang Fang; Li Yang; Zhengtao Wang
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.